October 24, 2025 a 08:39 am
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. presents a strong portfolio in the field of minimally invasive medical technology. Current analyst ratings suggest a cautiously optimistic perspective on the company's stock, bolstered by its pioneering technology and robust market presence. However, a certain level of divergence in opinions reflects uncertainties amidst potential market competitions and broader economic conditions.
Historical Stock Grades
Reviewing the latest data, Intuitive Surgical, Inc. maintains a solid standing with a blend of recommendations showcasing varying degrees of confidence. As of October 2025:
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 7 | |
| Buy | 15 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
Long-term trends reveal interesting dynamics in the weighting and count of analyst recommendations:
- The total number of Strong Buy ratings has moderately decreased over recent months, signaling tempered exuberance.
- Hold recommendations remain relatively consistent, suggesting a persistent cautious outlook amongst analysts.
- Overall analyst recommendations fluctuated minimally, indicating stable sentiment despite minor shifts in individual categories.
Percentage Trends
Observing percentage shifts across ratings, we observe:
- The proportion of Buy ratings shows a significant portion consistently above 50%, highlighting sustained optimism.
- There has been a slight upward trend in Hold ratings, reflecting greater caution or neutrality in analyst outlooks.
- Sell and Strong Sell categories continue to remain minimal, underscoring limited bearish sentiment.
- Encapsulating the rating trends, a notable shift from Strong Buy to Buy can be inferred in recent assessments.
Latest Analyst Recommendations
Recent analyst activities demonstrate consistent conservatism in rating ISRG:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-23 | Neutral | Neutral | UBS |
| 2025-10-22 | Overweight | Overweight | Wells Fargo |
| 2025-10-22 | Buy | Buy | Truist Securities |
| 2025-10-22 | Outperform | Outperform | Raymond James |
| 2025-10-22 | Overweight | Overweight | Piper Sandler |
Analyst Recommendations with Change of Opinion
Reviewing adjusted opinions provides insights into strategic pivots amongst analysts:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-09 | Sell | Hold | Deutsche Bank |
| 2024-12-02 | Overweight | Equal Weight | Morgan Stanley |
| 2024-11-19 | Buy | Hold | Erste Group |
| 2024-08-02 | Buy | Neutral | Redburn Atlantic |
| 2022-02-02 | Buy | Neutral | UBS |
Interpretation
Analysis of the recommendations reveals a prevailing sentiment of cautious optimism towards Intuitive Surgical, Inc., underpinned by strong buy ratings. The mixed nature of recent analyst adjustments indicates that while growth potential remains, challenges are recognized. The lack of any substantial bearish shift implies confidence in the company's core competencies, despite current market volatilities. Observations of stability in recommendations suggest that while opinions are slightly divergent, overall analyst confidence continues to support the stock's fundamental strengths.
Conclusion
Intuitive Surgical, Inc. remains a competent player within the medical technology niche, driven by its pioneering systems and services. Recent analyses reflect a nuanced balance of optimism and caution. While the company capitalizes on innovative healthcare solutions, the market responds to evolving performance metrics and external factors. Given the subtle decrease in fervor amongst some Buy ratings, stakeholders should maintain a balanced outlook, considering both emergent opportunities and potential headwinds. Overall, Intuitive Surgical's stability is bolstered by its entrenched market position and technological edge.